# FDA 483 - Matrix Pharmacorp Private Limited - September 01, 2025

Source: https://www.globalkeysolutions.net/records/483/matrix-pharmacorp-private-limited/9c8ec5f8-fa51-48d0-8542-153ac22123c6

> FDA 483 for Matrix Pharmacorp Private Limited on September 01, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Matrix Pharmacorp Private Limited
- Inspection Date: 2025-09-01
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: An FDA inspection of MATRIX PHARMACORP PRIVATE LIMITED, UNIT 10, an API manufacturer in Anakapalli Dist., India, revealed significant deficiencies. The firm failed to adequately validate analytical methods, lacked sufficient controls over computerized systems leading to data integrity concerns, and had unscientific sampling procedures for API release testing. These issues indicate a systemic breakdown in quality control and data management practices.

## Related Documents

- [483 - 2025-09-05](https://www.globalkeysolutions.net/records/483/matrix-pharmacorp-private-limited/defcaabc-41dd-4b4a-bc43-d3db0107fc2a)

## Related Officers

- [Ucheabuchi C. Chudi-nwankwor](https://www.globalkeysolutions.net/people/ucheabuchi-c-chudi-nwankwor/18b01d08-3cfd-4ace-97b2-5f54b6427661)

Company: https://www.globalkeysolutions.net/companies/matrix-pharmacorp-private-limited/3cbdd9ae-291e-406d-9e2c-5479410bf998

Office: https://www.globalkeysolutions.net/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3